chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Following injection of the vaccine, pt became dizzy and sweaty.  Pt had a decrease in consciousness  and was starting waiver as if she was passing out. She  was kept in the sitting position and we continued to speak with her and ask her to keep her eyes open,  and  she had trouble doing so. A pharmacy staff member called 911, for emergency care. Within 2 minutes the patient was able to answer questions and keep her eyes open. EMS came in and took over care. They took her blood pressure, which was 74/60. They asked if they could take her to the hospital. She asked to call her mom and/or roommate. The EMS reccomended that she let them take her to the hospital for fluids to increase her bp. She denied that against the medical advice of the EMS providers. She remained seated in the immunization room for atleast 20  minutes, after which her roommate came in and drove her home. I followed up with the patient and she confirmed that she was feeling mostly better, but did feel drowsy. I advised that she should reach out to her pcp to be evaluated regaurding the reaction.
Baby had a hard time swallowing food and bottle. Developed hives around his neck, shoulders and arm. Red bump at injection site. Fussy and vomited. Did not sleep well that night.  Called the doctor and they ignored my concerns.  Spoke with pediatric nurse friend and gave him an allergy medication and ibuprofen.
Information has been received from the mother of her 15 year old female daughter, who in November 2007 was vaccinated with GARDASIL and after receiving the first dose of GARDASIL, the patient experienced seizures and was diagnosed with "CMT". Upon internal review, seizures and was diagnosed with "CMT" was determined to be an other important medical event. Additional information has been requested.
Itching at injection site which spread to bilateral arms, legs and abdomen 4 minutes following injection.  50mg Benadryl PO administered to patient by co-workers in LTC facility.   HR 108, SaO2 98%, 5 min following injection.  Dizziness began 11 minutes following vaccine injection.  Patient laid in bed with elevated head.  HR 80, SaO2 98% 15 minutes following injection.  Tingling in lips mouth area began 30 minutes following vaccine injection.  911 called within 2 minutes of this and EpiPen 0.3mg dose administered at same time in left thigh.  HR 94, SaO2 98% 32 minutes following vaccine injection.  Ambulance arrived and patient stable, stating reduction in tingling of lip/mouth area and reduction in overall body itching.  Patient taken to ER, based on history of allergy to fish, and patient's agreement to be seen in ER.
A report was received from a healthcare professional on 10/24/2003 concerning 3 vaccinees of unknown gender less than 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date 3 vaccinees less than 4 years of age inadvertently received Fluvirin.  It was unknown at the time of the report whether or not the vaccinees had exhibited any signs or symptoms of an adverse reaction. There was insufficient information to determine the reporter's causality assessment. Update 1, 11/24/2003: Follow up information was received from a healthcare professional on 11/24/2003 indicating that the vaccinee was a 2 year old male.  The vaccinee experienced local redness at the site of injection an unspecified length of time after receiving 0.25ml Fluvirin on 10/17/2003.  The vaccinee also experienced fever, local swelling, bruising, soreness and redness on 10/18/2003.  The fever lasted for 2 days.  The local swelling, bruising, soreness and redness resolved 1 week later. Follow up pending.
flu like symptoms, sore throat, bad flare up from autoimmune, body pain, extreme fatigue, insomnia, non stop headaches, ear ringing, bowel issues, twitching, memory issues, chest pain
Relatively Severe Fatigue, Fever, Chills, Body Aches,  and Headache for approximately 72 hours
On 072206, noticed small papular lesion on L wrist.  Had a "patch" 3cmx15cm on L wrist just proximal to lesion.  States the patch was very itchy and prickly.  Then noticed papular lesions over both arms and both ankles.  10 - 12 total lesions noted.
10/12/2015: fever 101.8. 10/13/2015: fever 101.3. 10/14/2015: fever 102.5 fussy, cold like symptoms. 10/15/2015: fever 102.9 vomiting, cough, fussy, rash - seen by Dr.
on three separate incidents after 2nd  vaccine (not during the time I had Covid) I have had severe eczema? red painful itchy rash on neck, chest and shoulders after being exposed to sunlight.
The covid vaccination was forced on me, against my will via mandate. I am a US Federal worker and was threatened with the loss of my job if I did not unwillingly get the vaccine. After being forced by mandate I got the J and J vaccine on Friday 24 September 2021 and on Monday 27th September 2021 I started feeling the below symptoms which got worse throughout the day and the week. Headaches, shortness of breath, joint aches, dizziness and eye pain. I continue to have headaches all the time which I never suffered from before. These headaches have caused pain, suffering and anxiety which continues to grow. I went to my primary care physician on Wednesday 29th September 2021 and they order a COVID PMR test which came back negative. They also ordered and I had a Chest CT which they said did not show anything. As I now have headaches all the time, I am scheduled to go back to my primary care team for follow up on 11/04/21.
Hundreds of red inflamed itchy bumps on my back and left torso front side.  No relief from hot itchy bumps.  Pharmacy recommended taking an antihistamine on 01/19/2013.  No relief as of yet.  I am very sensitive to chemicals and I now recall how I was sensitive to thimerosal that used to be in contact lense solution in the 1970s.  I could not use it.  I was not told by the pharmacy that the vaccine had mercury based thimerosal in it.  I was not given the option of waiting for the vaccine that they pharmacy now has in stock without thimerosal.  If I had know that the administered vaccine had mercury based thimerosal as a preservative I would not have taken the injection.  I would have waited for the non-thimerosal version.
ErythemaMultiform Narrative: "Big feverish knot on my arm" for 4 days
On 03/13/2023 I started feeling more tired. 03/20/2023 I started having a Gout flare and then contacted my provider I was prescribed Prednisone.
Patient was given Covid-19 (Moderna) at 2300. We are the reporting facility. Pt did not receive vaccine by us or at our office. Patient was seen by our office after receiving the vaccine for Physical Exam. Pt was given the vaccine on 01/18/2021. He was seen in our office on 02/02/2021 and still had evidence of severe reaction. At this time he had 3 quarter size ulcerations, no drainage and minimal tenderness.  Pt's first sign of reaction was on 01/23/2021. He had fluid filled blister about the size of an adult hand on his right upper arm at the site of injection. He was seen at the Urgent Care on 01/24/2021 when he first noticed vaccine reaction. Pt was treated with Bactroban 2% ointment and Triamcinolone 0.5% ointment.
FEVER; DIDN'T FEEL GOOD; BLACK AND BLUE ARM AT INJECTION SITE; A LITTLE TIRED; This is a spontaneous report from a contactable consumer (patient). A 55-years-old female patient received first dose of BNT162B2 (Solution for injection; Lot number: EP2163 and expiration date was not reported) via an unspecified route of administration, as single dose for COVID-19 immunization in Apr2021. The patients medical history and concomitant medications were not reported. The patient experienced fever, did not feel good, black, and blue arm at injection site and was a little tired. Patient did miss two doses of self-due to this issue. The patient is feeling better. The outcome of the events was unknown.   No Follow-up attempts are needed. No further information is expected.
wrong vaccine/monovalent received instead of bivalent; No adverse event; This spontaneous case was reported by a patient family member or friend and describes the occurrence of WRONG PRODUCT ADMINISTERED (wrong vaccine/monovalent received instead of bivalent) and NO ADVERSE EVENT (No adverse event) in an 11-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 Vaccine (Dose 1), COVID-19 VACCINE (Booster dose) and Pfizer COVID-19 Vaccine (Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE, Pfizer COVID-19 Vaccine and Pfizer COVID-19 Vaccine.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (wrong vaccine/monovalent received instead of bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (wrong vaccine/monovalent received instead of bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.    Concomitant medications details were not reported by the reporter.  The reporter was trying to find out if her children were given the monovalent or bivalent. She thought patient was given the wrong vaccine at the pharmacy. The pharmacy told that they gave the children the monovalent, but they were scheduled for the bivalent vaccine. The reporter stated her child received two Pfizer doses and a booster. She stated patient had no adverse reaction.  Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-660593, US-MODERNATX, INC.-MOD-2022-660597 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-660593:Patient 2 US-MODERNATX, INC.-MOD-2022-660597:Patient 3
This spontaneous report was received from a physician refers to multiple unspecified patients of unknown age and gender. The patients pertinent medical history and concurrent conditions were not provided. On unknown dates, the patients were vaccinated with doses of M-M-R II (route, lot number and expiration date were not provided). On unknown dates, there was an incorrect product storage as the multiple unspecified patients were administered improperly stored M-M-R II. No adverse events were reported. It was unknown if the patients sought medical attention. The outcome of incorrect product storage and no adverse event was unknown. This is one of several reports received from the same source. Additional information has been requested.
Light headed or dizziness showed up on the 20th day following shot #1.  Other symptoms were sore shoulder and mild headache that appeared on the second day following the shot.  The soreness and headache were expected and if those were the only symptoms I would not have reported them.  The dizziness was unexpected and had not completely gone away at the time of my second shot on 02/09/2021.  After the second shot they dizziness has gotten slightly worse.  The soreness in the arm is WAY worse with the second shot and there is achiness in my back, shoulders and neck as well as a headache that comes and goes.  Again, The only symptom that I did not expect was the dizziness.
hand and fingers are having a throbbing pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (hand and fingers are having a throbbing pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (hand and fingers are having a throbbing pain). At the time of the report, PAIN IN EXTREMITY (hand and fingers are having a throbbing pain) outcome was unknown.            Concomitant medications were not provided.  Treatment information was not provided.   Reporter did not allow further contact
patient stated with her first dose of the covid-19 vaccine, she had severe back pain. she described that her pain was 12/10 and extended from her neck to her spine. her pain caused her to cry and she felt "strangled" by her pain. The pain lasted for about 30 minutes and she had to apply ice on it.  the pain occurred 8 hours after her 1st dose.
This spontaneous report was received from a pharmacy technician referring to an unknown number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB injection, intramuscularly, (lot # L040458, expiration date 04-FEB-2018), (dose was not reported). Concomitant medication information was not provided. Moreover, it was reported that the unspecified number of doses of RECOMBIVAX HB were exposed to a temperature excursion of 48.7 Fahrenheit degrees for 24 hours. However, no adverse events were reported and no product quality complaint (PQC) was involved. Additional information has been requested.
pt recv vax & pt devel a fever of 102 which lasted for 3 days & vomiting which lasted for 2 days;28JUN97 pt devel chickenpox;it was reported that child body was covered w/lesions;11JUL97 pt recovered;
pt recvd vax 2JUN93; that noc pt devel t104.8 that responded well to APAP;
The patient had an influenza vaccination on 09/27/10. Two days later on 09/29/10 the patient claims experiencing a severe right sided headache, 10/10, with brief bilateral loss of vision, then stated feeling numbness, tingling, and pain on left lower face and left shoulder area. The patient was hospitalized at an outside local hospital where she was examined and discharged on pain medications. On 10/03/10 the patient started experiencing bilateral lower extremity weakness starting from her feet and gradually ascending to bilateral thigh resulting in inability to move bilateral lower extremities. On 10/05/10 the patient went to primary care doctor where she was told she had Guillain-Barre syndrome and was sent to ER. On 10/05/10 the patient presented to the ER with bilateral lower extremity weakness for two to three days. Differential diagnosis post admission was Guillain-Barre syndrome versus transverse myelitis. Per neurology consult on 10/05/10, the patient has intact reflexes which makes the Guillain-Barre syndrome highly unlikely. The patient's weakness improved from 0/5 to 3/5 bilaterally. The patient underwent lumbar puncture on 10/08/10 and there was absence of pleocytosis. The patient was then discharged on 10/11/10 on stable condition being able to ambulate on a walker with follow up plan to attend neuromuscular clinic visit in one week. On 10/12/10, the result of HSV PCR in CSF that was sent on 10/08/10 came back positive. Therefore the patient was readmitted to hospital for further work up. Active HSV related radiculitis/transverse myelitis was considered. On 10/14/10 her bilateral lower extremity weakness was significantly improved from the day of admission and patient was oriented x4. Given the positive HSV PCR in CSF, Anti-HSV treatment was started and the patient was discharged on 10/14 and was instructed to follow up with neuromuscular clinic.
Information has been received from a medical assistant regarding an unspecified number of unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. The medical assistant reported that on unspecified dates an unspecified number of patients were administered improperly stored doses of GARDASIL 9 (lot # M042853 expiration 17-JUL-2019) unknown route for prophylaxis. No adverse effects were reported. The vaccines were stored at the temperature range of 47 degrees Fahrenheit and 77 degrees Fahrenheit for the time frame of 15 minutes. There were no previous temperature excursions. The call was made due to a data logger. All telephone attempts to obtain follow up information had been unsuccessful. Sender's Comments: US-009507513-1707USA002112: US-009507513-1708USA009538.
Information has been received from a nurse referring to a patient of unknown age and gender. No relevant medical history or concurrent conditions were reported. On an unknown date, the patient was vaccinated with a dose of improperly stored (GARDASIL 9) (lot # L037554, expiration date 25-DEC-2017; route was not reported) (incorrect product storage) (temperature/time frame: 9.3 Celsius degree for 1 hour, 10 minutes; back in range: yes; data logger: unknown). There were no previous excursions. No adverse effects were reported. Additional information has been requested.
Child was given Kinrix instead of DTAP and was also given IPOL on the same date. No known reactions from patient.
he had two or three patients that had red arms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (he had two or three patients that had red arms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (he had two or three patients that had red arms). At the time of the report, ERYTHEMA (he had two or three patients that had red arms) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2021-329591 (Patient Link).   Reporter did not allow further contact
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Tested positive day 9. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included PAXLOVID from 02Oct2023 to 06Oct2023. The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Rash covering arm and torso area, excluding the back region. Also on upper legs. Went from itchy to painful accompanied by headache and tiredness.; Rash covering arm and torso area, excluding the back region. Also on upper legs. Went from itchy to painful accompanied by headache and tiredness.; Headache; tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 06Aug2021 at 11:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: FA6780) via an unspecified route of administration in the left arm on 15Jul2021 at 18:00 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Aug2021 at 10:00, the patient experienced rash covering arm and torso area, excluding the back region, also on upper legs, went from itchy to painful accompanied by headache and tiredness. No fever involved. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash covering arm and torso area, excluding the back region also on upper legs, went from itchy to painful accompanied by headache and tiredness was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected
Moderna COVID-19 Vaccine EUA Fever starting night of shot lasting 4 days fever as high as 103.2 Chills, fatigue,body aches, sores in mouth and one outside of bottom lip, ringing in ears Felt just like I had Covid-19 all over again!!!!! Called Doctor and was told I was probably having a allergic reaction  to the shot and should feel better in a couple days. It took 4. Also asked if I should get the 2nd shot and was told yes, and I probably would have adverse side effects from that one as well.  I am supposed to receive that on March 4th 2021. I cant wait LOL
Explosive diarrhea, several times a day, primarily in mornings, occasionally in evening, usually starting at 4:00 am until system completely cleaned out.
Fever (101.2) few hours after vaccination. (+) headache. Fever lasted for 2 days. (+) vomit x 1.
with in 2 hours patient was complaining of pain in lower back, weakness, loose stols, achy muscles, and dizziness.
Rash under the same arm that vaccine given in. Went into clinic on 10/26/2011 and diagnosised with hidradenitis. Put on antibiotic.
Pt experienced periorbital swelling, conjuntival injection and wheezing. Pt treated with Benadryl, albuterol and Depo-Medrol
Yesterday, a day after I received the 3rd dose of Pfizer, I was at work and experienced an extreme shortness of breath and my heart was racing really fast. I felt like I was about to have an anxiety attack, and this feeling went on for about 1-2 hours. I have been diagnosed with anxiety in the past, but my anxiety hasn?t been bad for about 4 years now, and I haven?t experienced any kind of anxiety or panic attack for about 2 years, as I?ve gotten a pretty good grip on my anxiety. So, the events that happened yesterday were incredibly abnormal, and I was really confused as to what was going on, especially because I couldn?t identify what could?ve possibly triggered the event. I believe it may have been an effect of the vaccine.
Patient reports develop Hives 2 days after vaccine administration. Treatment=Benadryl. Outcome=Resolved
CHIEF COMPLAINT:   C/O Right Flank Pain since 1930. +Covid dx this past 2/17. Denies urination issues.   HISTORY OF PRESENT ILLNESS:     Patient is a 60-year-old female with history of anxiety, hypothyroidism that presents with flank pain.  Is located on the right, nonradiating.  It started suddenly this evening at 7:30 PM.  States she has never had pain this bad before with it.  Patient is worried it might be a urine infection as she has had some in the past that have been less severe.  She did not take anything for this prior to arrival.  Patient denies chest pain, shortness of breath, abdominal pain, vomiting, fever, chills.  Patient was diagnosed with Covid on the 17th